Search results
- 1.0503163 - BTÚ 2019 RIV eng P - Patent Document
Neužil, Jiří - Werner, L. - Štursa, J.
Tamoxifen derivatives for treatment of neoplastic diseases, especially with high HER2 protein level.
2018. Owner: J. Neužil, Biotechnologický ústav AV ČR, v. v. i., Smart Brain s.r.o., KKCG AG. Date of the patent acceptance: 31.05.2018. Patent Number: EA029881
Institutional support: RVO:86652036
Keywords : Mitochondrial targeting * Anticancer * Respiration
OECD category: Biochemistry and molecular biology
https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20180531&DB=&locale=en_EP&CC=EA&NR=029881B1&KC=B1&ND=4
Permanent Link: http://hdl.handle.net/11104/0294979 - 2.0503162 - BTÚ 2019 RIV eng P - Patent Document
Neužil, Jiří - Werner, L. - Štursa, J.
Tamoxifen derivatives for treatment of neoplastic diseases, especially with high HER2 protein level.
2018. Owner: J. Neužil, Biotechnologický ústav AV ČR, v. v. i., Smart Brain s.r.o., KKCG AG. Date of the patent acceptance: 15.08.2018. Patent Number: JP6375091
Institutional support: RVO:86652036
Keywords : Mitochondrial targeting * Anticancer * Respiration
OECD category: Biochemistry and molecular biology
https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20180815&DB=&locale=en_EP&CC=JP&NR=6375091B2&KC=B2&ND=4
Permanent Link: http://hdl.handle.net/11104/0294976 - 3.0503161 - BTÚ 2019 RIV eng P - Patent Document
Neužil, Jiří - Werner, L. - Štursa, J.
Tamoxifen derivatives for treatment of neoplastic diseases, especially with high HER2 protein level.
2018. Owner: J. Neužil, Biotechnologický ústav AV ČR, v. v. i., Smart Brain s.r.o., KKCG AG. Date of the patent acceptance: 08.08.2018. Patent Number: EP2989110
Institutional support: RVO:86652036
Keywords : Mitochondrial targeting * Anticancer * Respiration
OECD category: Biochemistry and molecular biology
https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20180808&DB=&locale=en_EP&CC=EP&NR=2989110B1&KC=B1&ND=4
Permanent Link: http://hdl.handle.net/11104/0294975 - 4.0503158 - BTÚ 2019 RIV eng P - Patent Document
Neužil, Jiří - Werner, L. - Štursa, J.
Tamoxifen derivatives for treatment of neoplastic diseases, especially with high HER2 protein level.
2018. Owner: J. Neužil, Biotechnologický ústav AV ČR, v. v. i., Smart Brain s.r.o., KKCG AG. Date of the patent acceptance: 26.06.2018. Patent Number: CA2909994
Institutional support: RVO:86652036
Keywords : Mitochondrial targeting * Anticancer * Respiration
OECD category: Biochemistry and molecular biology
https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20180531&DB=&locale=en_EP&CC=EA&NR=029881B1&KC=B1&ND=4
Permanent Link: http://hdl.handle.net/11104/0294973 - 5.0503157 - BTÚ 2019 RIV eng P - Patent Document
Neužil, Jiří - Werner, L. - Štursa, J.
Tamoxifen derivatives for treatment of neoplastic diseases, especially with high HER2 protein level.
2018. Owner: J. Neužil, Biotechnologický ústav AV ČR, v. v. i., Smart Brain s.r.o., KKCG AG. Date of the patent acceptance: 26.03.2018. Patent Number: UA116469
Institutional support: RVO:86652036
Keywords : Mitochondrial targeting * Anticancer * Respiration
OECD category: Biochemistry and molecular biology
http://base.ukrpatent.org/searchBul/search.php?action=viewdetails&dbname=invc&IdClaim=245383
Permanent Link: http://hdl.handle.net/11104/0294972 - 6.0503153 - BTÚ 2019 RIV eng P - Patent Document
Neužil, Jiří - Werner, L. - Štursa, J.
Tamoxifen derivatives for treatment of neoplastic diseases, especially with high HER2 protein level.
2018. Owner: J. Neužil, Biotechnologický ústav AV ČR, v. v. i., Smart Brain s.r.o., KKCG AG. Date of the patent acceptance: 23.03.2018. Patent Number: NZ713589
Institutional support: RVO:86652036
Keywords : Mitochondrial targeting * Anticancer * Respiration
OECD category: Biochemistry and molecular biology
https://app.iponz.govt.nz/app/Extra/IP/Mutual/Browse.aspx?sid=636808585975018936
Permanent Link: http://hdl.handle.net/11104/0294968 - 7.0503151 - BTÚ 2019 RIV eng P - Patent Document
Neužil, Jiří - Werner, L. - Štursa, J.
Tamoxifen derivatives for treatment of neoplastic diseases, especially with high HER2 protein level.
2018. Owner: J. Neužil, Biotechnologický ústav AV ČR, v. v. i., Smart Brain s.r.o., KKCG AG. Date of the patent acceptance: 12.03.2018. Patent Number: GEP20186868
Institutional support: RVO:86652036
Keywords : Mitochondrial targeting * Anticancer * Respiration
OECD category: Biochemistry and molecular biology
https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20180625&DB=&locale=en_EP&CC=GE&NR=P20186868B&KC=B&ND=4
Permanent Link: http://hdl.handle.net/11104/0294967 - 8.0503146 - BTÚ 2019 RIV eng P - Patent Document
Neužil, Jiří - Werner, L. - Štursa, J.
Tamoxifen derivatives for treatment of neoplastic diseases, especially with high HER2 protein level.
2018. Owner: J. Neužil, Biotechnologický ústav AV ČR, v. v. i., Smart Brain s.r.o., KKCG AG. Date of the patent acceptance: 20.02.2018. Patent Number: US9896466
Institutional support: RVO:86652036
Keywords : Mitochondrial targeting * Anticancer * Respiration
OECD category: Biochemistry and molecular biology
https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20180220&DB=&locale=en_EP&CC=US&NR=9896466B2&KC=B2&ND=4
Permanent Link: http://hdl.handle.net/11104/0294965 - 9.0502384 - BTÚ 2019 RIV eng P - Patent Document
Neužil, Jiří - Werner, L. - Štursa, J.
Tamoxifen derivatives for treatment of neoplastic diseases, especially with high HER2 protein level.
2018. Owner: J. Neužil, Biotechnologický ústav AV ČR, v. v. i., Smart Brain s.r.o., KKCG AG. Date of the patent acceptance: 15.02.2018. Patent Number: HK1216317
Institutional support: RVO:86652036
Keywords : Mitochondrial targeting * Anticancer * Respiration
OECD category: Biochemistry and molecular biology
http://ipsearch.ipd.gov.hk/patent/search/fssr01300_main.jsp?LANG=en&ITEM_KEY=8783683&PUB_CODE=B
Permanent Link: http://hdl.handle.net/11104/0294814 - 10.0481120 - BTÚ 2018 RIV eng P - Patent Document
Neužil, Jiří - Štursa, J. - Werner, L.
Tamoxifen derivatives for treatment of neoplastic diseases, especially with high HER2 protein level.
2017. Owner: J. Neužil, Biotechnologický ústav AV ČR, v. v. i., Smart Brain s.r.o., KKCG AG. Date of the patent acceptance: 28.07.2017. Patent Number: KR101764991
Institutional support: RVO:86652036
Keywords : Mitochondrial targeting * Anticancer * Respiration
OECD category: Cell biology
https://patents.google.com/patent/KR101764991B1/en
Permanent Link: http://hdl.handle.net/11104/0276726